Phospho-Cytokeratin 18 (Ser51) Antibody - #AF3849
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF3849, RRID:AB_2847163.
展开/折叠
Cell proliferation inducing gene 46 protein; Cell proliferation inducing protein 46; Cell proliferation-inducing gene 46 protein; CK 18; CK-18; CK18; CYK 18; CYK18; Cytokeratin 18; Cytokeratin endo B; Cytokeratin-18; K 18; K18; K1C18_HUMAN; KA18; Keratin 18; Keratin 18, type I; Keratin D; keratin, type I cytoskeletal 18; Keratin-18; Krt18;
抗原和靶标
A synthesized peptide derived from human Cytokeratin 18 around the phosphorylation site of Ser51.
Expressed in colon, placenta, liver and very weakly in exocervix. Increased expression observed in lymph nodes of breast carcinoma.
- P05783 K1C18_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MSFTTRSTFSTNYRSLGSVQAPSYGARPVSSAASVYAGAGGSGSRISVSRSTSFRGGMGSGGLATGIAGGLAGMGGIQNEKETMQSLNDRLASYLDRVRSLETENRRLESKIREHLEKKGPQVRDWSHYFKIIEDLRAQIFANTVDNARIVLQIDNARLAADDFRVKYETELAMRQSVENDIHGLRKVIDDTNITRLQLETEIEALKEELLFMKKNHEEEVKGLQAQIASSGLTVEVDAPKSQDLAKIMADIRAQYDELARKNREELDKYWSQQIEESTTVVTTQSAEVGAAETTLTELRRTVQSLEIDLDSMRNLKASLENSLREVEARYALQMEQLNGILLHLESELAQTRAEGQRQAQEYEALLNIKVKLEAEIATYRRLLEDGEDFNLGDALDSSNSMQTIQKTTTRRIVDGKVVSETNDTKVLRH
翻译修饰 - P05783 作为底物
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| M1 | Acetylation | Uniprot | |
| S2 | Acetylation | Uniprot | |
| S2 | Phosphorylation | Uniprot | |
| T4 | Phosphorylation | Uniprot | |
| S7 | Phosphorylation | Uniprot | |
| T8 | Phosphorylation | Uniprot | |
| S10 | Phosphorylation | Uniprot | |
| T11 | Phosphorylation | Uniprot | |
| Y13 | Phosphorylation | Uniprot | |
| S15 | Phosphorylation | Uniprot | |
| S18 | Phosphorylation | Uniprot | |
| S23 | Phosphorylation | Uniprot | |
| Y24 | Phosphorylation | Uniprot | |
| R27 | Methylation | Uniprot | |
| S30 | O-Glycosylation | Uniprot | |
| S30 | Phosphorylation | Uniprot | |
| S31 | O-Glycosylation | Uniprot | |
| S31 | Phosphorylation | Uniprot | |
| S34 | Phosphorylation | P06493 (CDK1) | Uniprot |
| Y36 | Phosphorylation | Uniprot | |
| S42 | Phosphorylation | Uniprot | |
| S44 | Phosphorylation | Uniprot | |
| R45 | Methylation | Uniprot | |
| S47 | Phosphorylation | Uniprot | |
| S49 | O-Glycosylation | Uniprot | |
| S49 | Phosphorylation | Uniprot | |
| R50 | Methylation | Uniprot | |
| S51 | Phosphorylation | Uniprot | |
| T52 | Phosphorylation | Uniprot | |
| S53 | Phosphorylation | P17252 (PRKCA) , Q9UBS0 (RPS6KB2) , P49137 (MAPKAPK2) , Q02156 (PRKCE) , P51812 (RPS6KA3) , Q14012 (CAMK1) , Q9UQM7 (CAMK2A) | Uniprot |
| R55 | Methylation | Uniprot | |
| S60 | Phosphorylation | Uniprot | |
| T65 | Phosphorylation | Uniprot | |
| K81 | Acetylation | Uniprot | |
| K81 | Sumoylation | Uniprot | |
| K81 | Ubiquitination | Uniprot | |
| T83 | Phosphorylation | Uniprot | |
| S86 | Phosphorylation | Uniprot | |
| R90 | Methylation | Uniprot | |
| S93 | Phosphorylation | Uniprot | |
| Y94 | Phosphorylation | Uniprot | |
| R97 | Methylation | Uniprot | |
| S100 | Phosphorylation | Uniprot | |
| S110 | Phosphorylation | Uniprot | |
| K111 | Acetylation | Uniprot | |
| K118 | Methylation | Uniprot | |
| K118 | Ubiquitination | Uniprot | |
| S127 | Phosphorylation | Uniprot | |
| Y129 | Phosphorylation | Uniprot | |
| K131 | Acetylation | Uniprot | |
| K131 | Methylation | Uniprot | |
| K131 | Ubiquitination | Uniprot | |
| K167 | Acetylation | Uniprot | |
| K167 | Methylation | Uniprot | |
| K167 | Sumoylation | Uniprot | |
| K167 | Ubiquitination | Uniprot | |
| Y168 | Phosphorylation | Uniprot | |
| S177 | Phosphorylation | Uniprot | |
| K187 | Acetylation | Uniprot | |
| K187 | Methylation | Uniprot | |
| K187 | Sumoylation | Uniprot | |
| K187 | Ubiquitination | Uniprot | |
| T192 | Phosphorylation | Uniprot | |
| T195 | Phosphorylation | Uniprot | |
| T201 | Phosphorylation | Uniprot | |
| K207 | Sumoylation | Uniprot | |
| K207 | Ubiquitination | Uniprot | |
| K214 | Acetylation | Uniprot | |
| K214 | Ubiquitination | Uniprot | |
| K215 | Ubiquitination | Uniprot | |
| K222 | Acetylation | Uniprot | |
| S230 | Phosphorylation | Uniprot | |
| K241 | Ubiquitination | Uniprot | |
| S242 | Phosphorylation | Uniprot | |
| K247 | Acetylation | Uniprot | |
| K247 | Sumoylation | Uniprot | |
| K247 | Ubiquitination | Uniprot | |
| Y256 | Phosphorylation | Uniprot | |
| K262 | Ubiquitination | Uniprot | |
| K269 | Sumoylation | Uniprot | |
| Y270 | Phosphorylation | Uniprot | |
| S272 | Phosphorylation | Uniprot | |
| T302 | Phosphorylation | Uniprot | |
| S305 | Phosphorylation | Uniprot | |
| S312 | Phosphorylation | Uniprot | |
| K317 | Acetylation | Uniprot | |
| K317 | Sumoylation | Uniprot | |
| K317 | Ubiquitination | Uniprot | |
| S319 | Phosphorylation | Uniprot | |
| S323 | Phosphorylation | Uniprot | |
| Y331 | Phosphorylation | Uniprot | |
| S347 | Phosphorylation | Uniprot | |
| Y363 | Phosphorylation | Uniprot | |
| K370 | Ubiquitination | Uniprot | |
| K372 | Sumoylation | Uniprot | |
| K372 | Ubiquitination | Uniprot | |
| T379 | Phosphorylation | Uniprot | |
| Y380 | Phosphorylation | Uniprot | |
| S398 | Phosphorylation | Uniprot | |
| S399 | Phosphorylation | Uniprot | |
| S401 | Phosphorylation | Uniprot | |
| T404 | Phosphorylation | Uniprot | |
| K407 | Ubiquitination | Uniprot | |
| T409 | Phosphorylation | Uniprot | |
| K417 | Acetylation | Uniprot | |
| K417 | Sumoylation | Uniprot | |
| K417 | Ubiquitination | Uniprot | |
| S420 | Phosphorylation | Uniprot | |
| T422 | Phosphorylation | Uniprot | |
| T425 | Phosphorylation | Uniprot | |
| K426 | Acetylation | Uniprot | |
| K426 | Methylation | Uniprot | |
| K426 | Sumoylation | Uniprot | |
| K426 | Ubiquitination | Uniprot |
研究背景
Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection.
Phosphorylation at Ser-34 increases during mitosis. Hyperphosphorylated at Ser-53 in diseased cirrhosis liver. Phosphorylation increases by IL-6.
Proteolytically cleaved by caspases during epithelial cell apoptosis. Cleavage occurs at Asp-238 by either caspase-3, caspase-6 or caspase-7.
O-GlcNAcylation increases solubility, and decreases stability by inducing proteasomal degradation.
Cytoplasm>Perinuclear region. Nucleus>Nucleolus.
Expressed in colon, placenta, liver and very weakly in exocervix. Increased expression observed in lymph nodes of breast carcinoma.
Heterotetramer of two type I and two type II keratins. KRT18 associates with KRT8. Interacts with the thrombin-antithrombin complex (By similarity). Interacts with PNN and mutated CFTR. Interacts with YWHAE, YWHAH and YWHAZ only when phosphorylated. Interacts with DNAJB6, TCHP and TRADD. Interacts with FAM83H. Interacts with EPPK1 (By similarity).
(Microbial infection) Interacts with hepatitis C virus/HCV core protein.
Belongs to the intermediate filament family.
研究领域
· Human Diseases > Infectious diseases: Bacterial > Pathogenic Escherichia coli infection.
· Organismal Systems > Endocrine system > Estrogen signaling pathway. (View pathway)
限制条款
产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.